HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

MBRX: Metabasis Therapeutics Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
METABASIS THERAPEUTICS INC (NASD)
MBRX 0.39 0.01 (2.63%) Vol.  479,108 14.00 CST

Oct 29, 2009 Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
Oct 28, 2009 BiomedReports: News and FDA Updates for ARIAD (NASDAQ:ARIA), PolyMedix (OTC:PYMX), Ligand (NASDAQ:LGND) Metabasis (NASDAQ:MBRX)
Oct 27, 2009 Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Oct 27, 2009 Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Sep 18, 2009 Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements
Sep 09, 2009 Metabasis Therapeutics Receives Notice of Delisting from Nasdaq Capital Market
Sep 07, 2009 Metabasis Therapeutics CEO Resigns
Sep 03, 2009 PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, September 3, 2009: LVLT, MBRX, INOD, CRTX, CSKI and WFMI.
Sep 03, 2009 MBRX: Hires Financial Advisor to Evaluate Strategic Alternatives
Sep 03, 2009 Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives
Sep 02, 2009 BUYINS.NET: 49.74% Of All NASDAQ Trading Tuesday Was Short Selling. MBRX, XTXI, ISPH, LOPE, SMSI, ZBRA Highest % Of Daily Trading Volume Short
Sep 01, 2009 MRK: President and CEO Dr. Mark Erion Leaving to Join Merck
Sep 01, 2009 Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
Aug 11, 2009 Metabasis Therapeutics Reports 2Q 2009 Financial Results
Aug 07, 2009 MBRX: Q2 Earnings Call @ 08:30 ET Today [delayed]
 
ZACKS COMMENTARY FOR MBRX

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research